BACKGROUND: Mutations in the thanatos-associated protein domain containing apoptosis-associated protein 1 gene (THAP1) are responsible for adult-onset isolated dystonia (DYT6). However, no neuropathological studies of genetically proven DYT6 cases have been previously reported. OBJECTIVE: We report the first detailed neuropathological investigation carried out on two DYT6 brains. METHODS: Genetic screening for THAP1 gene mutations using standard Sanger polymerase chain reaction sequencing identified 2 cases, 1 with a known pathogenic mutation and the other with a novel mutation. A detailed neuropathological assessment of the cases was performed. RESULTS: Both DYT6 cases showed no significant neurodegeneration and no specific disease-related pathology. CONCLUSIONS: No neuropathological features that could be defined as hallmark features of DYT6 dystonia were identified. Our study supports the notion that in isolated dystonia, there is no significant neurodegeneration or morphological lesions that can be identified using routine methods.
BACKGROUND: Mutations in the thanatos-associated protein domain containing apoptosis-associated protein 1 gene (THAP1) are responsible for adult-onset isolated dystonia (DYT6). However, no neuropathological studies of genetically proven DYT6 cases have been previously reported. OBJECTIVE: We report the first detailed neuropathological investigation carried out on two DYT6 brains. METHODS: Genetic screening for THAP1 gene mutations using standard Sanger polymerase chain reaction sequencing identified 2 cases, 1 with a known pathogenic mutation and the other with a novel mutation. A detailed neuropathological assessment of the cases was performed. RESULTS: Both DYT6 cases showed no significant neurodegeneration and no specific disease-related pathology. CONCLUSIONS: No neuropathological features that could be defined as hallmark features of DYT6 dystonia were identified. Our study supports the notion that in isolated dystonia, there is no significant neurodegeneration or morphological lesions that can be identified using routine methods.
Authors: Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak Journal: Neurobiol Aging Date: 2003 Mar-Apr Impact factor: 4.673
Authors: Mark S LeDoux; Jianfeng Xiao; Monika Rudzińska; Robert W Bastian; Zbigniew K Wszolek; Jay A Van Gerpen; Andreas Puschmann; Dragana Momčilović; Satya R Vemula; Yu Zhao Journal: Parkinsonism Relat Disord Date: 2012-02-28 Impact factor: 4.891
Authors: Katja Lohmann; Nils Uflacker; Alev Erogullari; Thora Lohnau; Susen Winkler; Andreas Dendorfer; Susanne A Schneider; Alma Osmanovic; Marina Svetel; Andreas Ferbert; Simone Zittel; Andrea A Kühn; Alexander Schmidt; Eckart Altenmüller; Alexander Münchau; Christoph Kamm; Matthias Wittstock; Andreas Kupsch; Elena Moro; Jens Volkmann; Vladimir Kostic; Frank J Kaiser; Christine Klein; Norbert Brüggemann Journal: Eur J Hum Genet Date: 2011-08-17 Impact factor: 4.246
Authors: J L Holton; S A Schneider; T Ganesharajah; S Gandhi; C Strand; P Shashidharan; J Barreto; N W Wood; A J Lees; K P Bhatia; T Revesz Journal: Neurology Date: 2008-02-26 Impact factor: 9.910
Authors: Alev Erogullari; Ronja Hollstein; Philip Seibler; Diana Braunholz; Eva Koschmidder; Reinhard Depping; Juliane Eckhold; Thora Lohnau; Gabriele Gillessen-Kaesbach; Anne Grünewald; Aleksandar Rakovic; Katja Lohmann; Frank J Kaiser Journal: Biochim Biophys Acta Date: 2014-08-01
Authors: Samuel B Burnett; Lauren S Vaughn; Joelle M Strom; Ashley Francois; Rekha C Patel Journal: J Cell Biochem Date: 2019-06-27 Impact factor: 4.429
Authors: Zuchra Zakirova; Tomas Fanutza; Justine Bonet; Ben Readhead; Weijia Zhang; Zhengzi Yi; Genevieve Beauvais; Thomas P Zwaka; Laurie J Ozelius; Robert D Blitzer; Pedro Gonzalez-Alegre; Michelle E Ehrlich Journal: PLoS Genet Date: 2018-01-24 Impact factor: 5.917
Authors: Meike E van der Heijden; Dominic J Kizek; Ross Perez; Elena K Ruff; Michelle E Ehrlich; Roy V Sillitoe Journal: J Physiol Date: 2021-01-09 Impact factor: 5.182